Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Myelodysplastic-Myeloproliferative Diseases × durvalumab × 1 year × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 75 Lung Neoplasms 43 Carcinoma, Hepatocellular 37 Small Cell Lung Carcinoma 29 Biliary Tract Neoplasms 17 Cholangiocarcinoma 16 Urinary Bladder Neoplasms 15 Breast Neoplasms 15 Neoplasms 11 Liver Neoplasms 11 Squamous Cell Carcinoma of Head and Neck 10 Ovarian Neoplasms 10 Carcinoma 10 Triple Negative Breast Neoplasms 9 Pancreatic Neoplasms 8 Neoplasm Metastasis 8 Gallbladder Neoplasms 7 Esophageal Neoplasms 7 Stomach Neoplasms 6 Colorectal Neoplasms 6 Prostatic Neoplasms 5 Melanoma 5 Endometrial Neoplasms 5 Adenocarcinoma 5 Neoplasms by Site 4 Mesothelioma 4 Carcinoma, Squamous Cell 4 Carcinoma, Renal Cell 4 Adenocarcinoma Of Esophagus 4 Uterine Cervical Neoplasms 3

Interventions

Specimen Handling 7 Biopsy 6 Cyclophosphamide 5 ruxolitinib 4 Mycophenolic Acid 4 Busulfan 4 fludarabine phosphate 3 fludarabine 3 Whole-Body Irradiation 3 Tacrolimus 3 Melphalan 3 Injections 3 Decitabine 3 Cyclosporine 3 Azacitidine 3 venetoclax 2 decitabine and cedazuridine drug combination 2 Sirolimus 2 Methotrexate 2 Granulocyte Colony-Stimulating Factor 2 veliparib 1 tocilizumab 1 tagraxofusp 1 posaconazole 1 peginterferon alfa-2b 1 onvansertib 1 merphos 1 iadademstat 1 gilteritinib 1 fedratinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡